Atlantic Pharmaceuticals President Named Health Care Hero Finalist in Atlanta Business Chronicle for Drug Abuse Deterrent Technology

ATLANTA, May 20, 2013 /PRNewswire/ -- Atlantic Pharmaceuticals, Inc., a specialty pharmaceutical company that has developed and is commercializing a unique technology to deter prescription drug abuse today announced that its founder and President, Anthony Soscia, has been chosen as a finalist for the Atlanta Business Chronicle's Health-Care Heroes Awards. The awards are presented annually by the Atlanta Business Chronicle to honor individuals and organizations demonstrating excellence and deserving recognition in the health-care community. From the doctors finding cures for deadly diseases to organizations serving our community's health care needs and allied professionals making a difference in the lives of many.

Atlantic's patented abuse deterrent platform has been designed to resist attempts to easily extract a drug from an oral dosage form and may sequester and reduce drug release of a pharmaceutical that has been subjected to a variety of physical methods of tampering and abuse. The technology can be applied to immediate as well as sustained release drug candidates such as oxycodone. "We believe SMART/Script is a unique technology that may have a significant impact on prescription drug abuse and misuse and are honored by the Health Care Heroes recognition," said Anthony Soscia, President of Atlantic Pharmaceuticals.

About SMART/Script

SMART/Script (SMART, Simple, controllable, resistant, insoluble, physical trap) a novel, patented drug delivery technology, was designed to prevent easy drug extraction and to deter the abuse of medications via known routes of abuse or misuse, including chewing, snorting, and injecting. Orally delivered prescription pharmaceuticals, such as narcotics, are frequently subjected to abuse and misuse via chewing and swallowing or crushing and either snorting or injecting the resultant powder in order to obtain a fast euphoria. A product formulated with SMART/Script, however, resists extraction in water or alcohol and can be used with a broad range of opioids and non-opioids in immediate or extended release forms. SMART/Script is also unique among competitive technologies in that physical manipulation, such as chewing or crushing, may result in reducing the release of the drug as opposed to increasing it.

About Atlantic Pharmaceuticals, Inc.

Atlantic Pharmaceuticals is a specialty pharmaceutical company using its patented technology to produce novel therapeutics that resist attempts at tampering and may be useful to reduce abuse of certain prescription drugs. Based on the Company's proprietary technology, SMART/Script, Atlantic is developing a pipeline of abuse-deterrent products that are nearing pivotal testing.

The Health-Care Heroes Award winners were revealed at the 16th annual award presentation dinner on May 16 at the Cobb Energy Centre.

Please visit atlanticpharma.com for more information.

Contact: Anthony Soscia, President
Email
404-994-5135

This press release was issued through eReleases® Press Release Distribution. For more information, visit http://www.ereleases.com.

SOURCE Atlantic Pharmaceuticals, Inc.